65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79726D0132
- Awardee
-
Catalyst Pharmaceuticals, Inc. UEI J1B2ARLKWN53
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment Pre-Solicitation · M5Q50A03R8 · Posted Jun 21, 2018
- Last date to order 8% complete
- IDV ceiling
- $105,895,620.00
- Award type
- Multiple award
- Who can order
- All agencies
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
GSA issued a Federal Supply Schedule contract to Catalyst Pharmaceuticals, Inc. on June 1, 2026, under Schedule 65 I B (Drugs, Pharmaceuticals, & Hematology Related Products), with a ceiling value of $105.895 million and an ultimate completion date of May 31, 2031. The contract is a multiple-award vehicle with no set-aside designation.
Catalyst Pharmaceuticals specializes in rare disease therapies, particularly Firdapse (amifampridine) 10mg tablets, an FDA-approved treatment for Lambert-Eaton myasthenic syndrome. The company operates as a prime contractor without reliance on subcontractors for its primary product lines and maintains its principal facility in Bartlett, Tennessee.
Under prior delivery orders against the Pharmaceuticals and Drugs Federal Supply Schedule, Catalyst Pharmaceuticals has supplied the Department of Veterans Affairs across multiple Veterans Integrated Service Networks since 2021. The company currently holds a $5.5 million single-award Blanket Purchase Agreement with the Veterans Health Administration National Acquisition Center, effective through July 25, 2026, enabling multiple VISNs to place individual delivery orders against the established ceiling. All prior awards have been structured as firm fixed-price contracts without set-aside designations.
This Schedule contract provides a multi-agency catalog vehicle through which federal agencies can place orders against Catalyst Pharmaceuticals' approved price list for specialized pharmaceutical products, streamlining procurement and ensuring consistent product availability across the federal healthcare system.
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79726A0018 | National Acquisition Center (VA) | $15,500,000 |
Quick answers
Who was awarded contract 36F79726D0132?
36F79726D0132 was awarded to Catalyst Pharmaceuticals, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on June 1, 2026.
How much is contract 36F79726D0132 worth?
36F79726D0132's own ceiling is $105,895,620.
Who can order from contract 36F79726D0132?
36F79726D0132 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79726D0132 part of a contract vehicle?
Yes. 36F79726D0132 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79726D0132 competed?
The extent of competition for 36F79726D0132 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV